{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:19:07Z","timestamp":1783430347259,"version":"3.54.6"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      Many people living with an inflammatory bowel disease (IBD) experience persistent abdominal symptoms even in the absence of active inflammation. These symptoms are referred to as\n                      <jats:italic toggle=\"yes\">irritable bowel syndrome (IBS)\u2013like<\/jats:italic>\n                      symptoms. Gastrointestinal-specific anxiety (GSA) is a common feature of disorders of gut-brain interaction and may also be relevant in patients with IBD experiencing IBS-like symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study examined the associations between psychological variables and GSA in individuals with IBD in different states of disease activity (n=308, age: 42.4\u00b119.4; female: 183, male: 125). In two subsamples of 83 patients (age: 41.2\u00b115.9; female: 37, male: 46) and 70 patients (age: 42.1\u00b116.1; female: 32, male: 38), links to single-nucleotide polymorphisms (SNPs) in genes related to serotonin signaling and serum tryptophan metabolites, respectively, were explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Psychological variables including anxiety (\u03b2=.393,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt;.001) and depression (\u03b2=.284,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt;.001) predicted GSA levels. Genetic analyses revealed associations for serotonergic variants; however, none of these associations remained statistically significant after correction for multiple testing. While disease activity was linked to GSA (\u03b2=.171,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =.002), inflammatory biomarkers and tryptophan metabolites did not exhibit any significant associations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings suggest that GSA as a specific type of anxiety is strongly related to psychological symptoms in IBD. Anxiety was the strongest predictor of GSA, contributing even more strongly to GSA than disease activity. Screening patients for GSA could help to detect disturbances in gut-brain interactions and improve individualized treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/psy.0000000000001493","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:00:43Z","timestamp":1779789643000},"page":"572-580","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal-specific Anxiety in IBD: Associations With Disease Activity, Psychological Symptoms, and Serotonergic Polymorphisms"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-8348","authenticated-orcid":false,"given":"Konstantina","family":"Atanasova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-2614","authenticated-orcid":false,"given":"Stefanie","family":"Mellein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Louise","family":"Knoedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8983-9037","authenticated-orcid":false,"given":"Vivianne Dorothee","family":"Niehaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil","family":"Mirkhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp Arthur","family":"Thomann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias Philip Alexander","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-4284","authenticated-orcid":false,"given":"Anne Kerstin","family":"Thomann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"R1-20260707","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","article-title":"Brain-gut interactions in inflammatory bowel disease","volume":"144","author":"Bonaz","year":"2013","journal-title":"Gastroenterology"},{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/MEG.0000000000000921","article-title":"The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission","volume":"29","author":"Hoekman","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/gutjnl-2024-333565","article-title":"Recent advances in clinical practice: mastering the challenge\u2014managing IBS symptoms in IBD","volume":"74","author":"Wellens","year":"2025","journal-title":"Gut"},{"key":"R5-20260707","first-page":"89","article-title":"The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index","volume":"69","author":"Labus","year":"2007","journal-title":"Biopsychosocial Sci Med"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ibd\/izy235","article-title":"Increased burden of psychiatric disorders in inflammatory bowel disease","volume":"25","author":"Bernstein","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10620-019-05488-8","article-title":"Presence of irritable bowel syndrome symptoms in quiescent inflammatory bowel disease is associated with high rate of anxiety and depression","volume":"64","author":"Perera","year":"2019","journal-title":"Dig Dis Sci"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"e14384","DOI":"10.1111\/nmo.14384","article-title":"The visceral sensitivity index: a novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease","volume":"34","author":"Trieschmann","year":"2022","journal-title":"Neurogastroenterol Motility"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1080\/13548506.2018.1476722","article-title":"Examining the mediational role of psychological flexibility, pain catastrophizing, and visceral sensitivity in the relationship between psychological distress, irritable bowel symptom frequency, and quality of life","volume":"23","author":"Cassar","year":"2018","journal-title":"Psychol Health Med"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/apt.17202","article-title":"Systematic review: the role of psychological stress in inflammatory bowel disease","volume":"56","author":"Black","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/tp.2011.29","article-title":"How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure","volume":"1","author":"Kobiella","year":"2011","journal-title":"Transl Psychiatry"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.12998\/wjcc.v8.i9.1632","article-title":"Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: associations with abdominal pain, visceral hypersensitivity and psychological performance","volume":"8","author":"Qin","year":"2020","journal-title":"World J Clin Cases"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrgastro.2015.206","article-title":"Lessons learned \u2014 resolving the enigma of genetic factors in IBS","volume":"13","author":"Gazouli","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1111\/jcmm.16736","article-title":"The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome","volume":"25","author":"Mohr","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12888-018-1850-4","article-title":"Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression","volume":"18","author":"Lam","year":"2018","journal-title":"BMC Psychiatry"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","article-title":"Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases","volume":"153","author":"Nikolaus","year":"2017","journal-title":"Gastroenterology"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav Immun"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","article-title":"The kynurenine pathway in major depression: What we know and where to next","volume":"127","author":"Brown","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-021-02175-2","article-title":"Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease","volume":"18","author":"Chen","year":"2021","journal-title":"J Neuroinflammation"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/cei.13276","article-title":"Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?","volume":"197","author":"Moulton","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1136\/gut.2004.041657","article-title":"Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls","volume":"53","author":"Kilkens","year":"2004","journal-title":"Gut"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41398-024-02971-3","article-title":"General and anxiety-linked influences of acute serotonin reuptake inhibition on neural responses associated with attended visceral sensation","volume":"14","author":"Livermore","year":"2024","journal-title":"Transl Psychiatry"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"315","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2036.2004.02007.x","article-title":"The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale","volume":"20","author":"Labus","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"issue":"suppl 1","key":"R29-20260707","doi-asserted-by":"crossref","first-page":"i81","DOI":"10.1136\/gut.51.suppl_1.i81","article-title":"Serotonergic modulation of visceral sensation: lower gut","volume":"51","author":"Camilleri","year":"2002","journal-title":"Gut"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic variation of human serotonin transporter gene expression","volume":"66","author":"Heils","year":"1996","journal-title":"J Neurochem"},{"key":"R31-20260707","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/hmg\/ddn195","article-title":"First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome","volume":"17","author":"Kapeller","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R32-20260707","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/mol.106.032144","article-title":"Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E","volume":"72","author":"Niesler","year":"2007","journal-title":"Mol Pharmacol"},{"key":"R33-20260707","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728222.11.4.527","article-title":"The 5-HT3 receptor as a therapeutic target","volume":"11","author":"Thompson","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"R34-20260707","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5056\/jnm15138","article-title":"Association of the serotonin receptor 3E gene as a functional variant in the MicroRNA-510 target site with diarrhea predominant irritable bowel syndrome in Chinese women","volume":"22","author":"Zhang","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"R35-20260707","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1053\/j.gastro.2011.03.011","article-title":"The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome","volume":"140","author":"Kilpatrick","year":"2011","journal-title":"Gastroenterology"},{"key":"R36-20260707","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00109-022-02244-w","article-title":"The serotonin receptor 3E variant is a risk factor for female IBS-D","volume":"100","author":"Fritz","year":"2022","journal-title":"J Mol Med"},{"key":"R37-20260707","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/apt.15420","article-title":"Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron","volume":"50","author":"Gunn","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R38-20260707","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/ibd\/izy068","article-title":"The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease","volume":"24","author":"Bernstein","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R39-20260707","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpsychores.2014.12.004","article-title":"Concerns and worries in people living with inflammatory bowel disease (IBD): a mixed methods study","volume":"78","author":"Keeton","year":"2015","journal-title":"J Psychosom Res"},{"key":"R40-20260707","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","article-title":"A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"key":"R41-20260707","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpsycho.2017.02.006","article-title":"The serotonin transporter polymorphism (5-HTTLPR) and coping strategies influence successful emotion regulation in an acute stress situation: physiological evidence","volume":"114","author":"Plieger","year":"2017","journal-title":"Int J Psychophysiol"},{"key":"R42-20260707","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/da.20660","article-title":"The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms","volume":"27","author":"Goldman","year":"2010","journal-title":"Depress Anxiety"},{"key":"R43-20260707","first-page":"19","article-title":"Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy","volume":"5","author":"Kenna","year":"2012","journal-title":"Pharmgenomics Pers Med"},{"key":"R44-20260707","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5056\/jnm16001","article-title":"The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments","volume":"22","author":"Farzaei","year":"2016","journal-title":"J Neurogastroenterol Motil"}],"container-title":["Biopsychosocial Science and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PSY.0000000000001493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:00:40Z","timestamp":1783429240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PSY.0000000000001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000001493","relation":{},"ISSN":["2998-8748","2998-8756"],"issn-type":[{"value":"2998-8748","type":"print"},{"value":"2998-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"2025-05-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}